Title : Ipragliflozin: A novel sodium-glucose cotransporter 2 inhibitor developed in Japan.

Pub. Date : 2015 Feb 15

PMID : 25685284






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Ipragliflozin: A novel sodium-glucose cotransporter 2 inhibitor developed in Japan. ipragliflozin solute carrier family 5 member 2 Homo sapiens
2 Ipragliflozin is highly selective for SGLT2. ipragliflozin solute carrier family 5 member 2 Homo sapiens
3 Ipragliflozin (highly selective SGLT2 inhibitor) improves glycemic control and reduces body weight and lowers hypoglycemic risk and abdominal symptoms. ipragliflozin solute carrier family 5 member 2 Homo sapiens